摘要
目的探讨莫西沙星在肺炎治疗中的临床效果。方法选取2020年10月—2022年10月本院收治的100例肺炎患者为研究对象,并按照电脑随机法分为对照组和实验组,每组50例。其中,对照组采用左氧氟沙星,实验组莫西沙星,持续治疗7日后,对比两个组别疾病症状改善情况、肺功能指标以及治疗总有效率。结果①实验组患者咳嗽缓解时间、体温恢复正常时间、肺啰音消失时间短于对照组(P<0.05);②实验组肺功能指标(FVC、FEV1、FEV1/FVC)高于对照组(P<0.05);③实验组总有效率高于对照组(P<0.05)。结论针对肺炎患者的治疗,莫西沙星展现出显著的治疗优势。经过临床验证,该药物能减轻患者疾病症状,提升整体治疗效率。同时,莫西沙星在改善肺功能指标方面也表现出色,这为其在医疗领域中的广泛应用提供了强有力的支持,展现了其高度的安全性和推广价值。
Objective To discuss ultimate effect of moxifloxacin drug treatment after pneumonia outbreak.Methods The paper chose 100 patients diagnosed with pneumonia from October 2020 to October 2022 for statistical analysis,and divided them into two groups based on computer randomization,including control group and experimental group.During treatment,control group was treated with levofloxacin and experimental group with moxifloxacin,50 cases in each group.After 7 days of continuous treatment,the improvement of disease symptoms,lung function indexes and the total treatment effective rate of the two groups were compared.Results①The time of cough relief,temperature return to normal and lung rales disappearance in the experimental group were shorter than those in the control group(P<0.05);②The pulmonary function indexes(FVC,FEV1,FEV1/FVC)of the experimental group were higher than those of the control group(P<0.05);③The total effective rate of experimental group was higher than that of control group(P<0.05).Conclusion Moxifloxacin has significant therapeutic advantages in the treatment of patients with pneumonia.After clinical verification,the drug can reduce the disease symptoms of patients and improve the overall treatment efficiency.At the same time,moxifloxacin also performed well in improving lung function indicators,which provided strong support for its wide application in the medical field,demonstrating its high safety and promotion value.
作者
潘晨
PAN Chen(Suzhou High Tech Zone People's Hospital,Suzhou,Jiangsu 215000)
出处
《智慧健康》
2024年第19期31-33,共3页
Smart Healthcare
关键词
肺炎患者
肺功能指标
总有效率
莫西沙星
左氧氟沙星
Pneumonia patients
Pulmonary function index
Total effective rate
Moxifloxacin
Levofloxacin
